Nvidia to Buy a Minority Stake in France’s Doctolib
20 Articles
20 Articles
The Californian company must become a minority shareholder of the medical platform, in order to enable it to have "a sovereign AI trained from its models and data", both groups announced this Tuesday.
This participation of this major flea player in the capital of the French platform is intended to "launch the revolution of artificial intelligence in Europe", said Nvidia's boss Jensen Huang.
The company will enter the capital of Doctolib as a minority shareholder, without a seat on the board of directors. The owner of Nvidia also indicated that he has invested in the French companies of IA
With its chip products, Nvidia is the central engine of the AI boom. Now the US Group is joining Doctolib. The French are hoping to gain more AI expertise for their platform.
Coverage Details
Bias Distribution
- 40% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
